Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

JM Llovet, T De Baere, L Kulik, PK Haber… - Nature reviews …, 2021 - nature.com
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality and
has an increasing incidence worldwide. Locoregional therapies, defined as imaging-guided …

EASL clinical practice guidelines: management of hepatocellular carcinoma

PR Galle, A Forner, JM Llovet, V Mazzaferro… - Journal of …, 2018 - Elsevier
Liver cancer is the fifth most common cancer and the second most frequent cause of cancer-
related death globally. Hepatocellular carcinoma represents about 90% of primary liver …

Percutaneous treatment of hepatocellular carcinoma: state of the art and innovations

JC Nault, O Sutter, P Nahon, N Ganne-Carrié… - Journal of …, 2018 - Elsevier
Percutaneous treatment of hepatocellular carcinoma (HCC) encompasses a vast range of
techniques, including monopolar radiofrequency ablation (RFA), multibipolar RFA …

A single-center retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases

K Han, JH Kim, SG Yang, SH Park, HK Choi, SY Chun… - Radiology, 2021 - pubs.rsna.org
Background Local tumor progression (LTP) is associated with poorer survival in patients
undergoing radiofrequency ablation (RFA) for colorectal liver metastasis (CLM). An …

Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: propensity score analyses of long-term outcomes

S Lee, TW Kang, DI Cha, KD Song, MW Lee… - Journal of …, 2018 - Elsevier
Background & Aims The therapeutic outcomes of surgical resection (SR) or radiofrequency
ablation (RFA) for perivascular hepatocellular carcinoma (HCC) have not been compared …

Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma< 3 cm: emphasis on association of local …

MW Lee, D Kang, HK Lim, J Cho, DH Sinn, TW Kang… - European …, 2020 - Springer
Objectives The purpose of this study was to evaluate the 10-year overall survival and local
tumor progression (LTP) of percutaneous radiofrequency ablation (RFA) for single nodular …

Laparoscopic liver resection versus percutaneous radiofrequency ablation for small single nodular hepatocellular carcinoma: comparison of treatment outcomes

DH Lee, JW Kim, JM Lee, JM Kim, MW Lee, H Rhim… - Liver cancer, 2021 - karger.com
Background: Treatment outcomes of laparoscopic liver resection (LLR) and percutaneous
radiofrequency ablation (p-RFA) for small single hepatocellular carcinomas (HCCs) have …

The local efficacy and influencing factors of ultrasound-guided percutaneous microwave ablation in colorectal liver metastases: a review of a 4-year experience at a …

S Qin, GJ Liu, M Huang, J Huang, Y Luo… - International Journal …, 2019 - Taylor & Francis
Purpose: To investigate the clinical effectiveness and safety of ultrasound (US)-guided
percutaneous microwave ablation (MWA) for colorectal liver metastasis (CRLM) and …

Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched study

H Zheng, K Liu, Y Yang, B Liu, X Zhao, Y Chen… - European …, 2022 - Springer
Objectives Thermal ablation is now accepted as one of the curative treatments for patients
with early-stage hepatocellular carcinoma (HCC), but the efficacy of this treatment for …

Percutaneous cryoablation for perivascular hepatocellular carcinoma: therapeutic efficacy and vascular complications

R Kim, TW Kang, DI Cha, KD Song, MW Lee, H Rhim… - European …, 2019 - Springer
Objectives To evaluate the therapeutic efficacy of and vascular complications associated
with percutaneous cryoablation for the treatment of perivascular HCC. Methods Between …